Search
  • Leadership & Board of Directors
  • Investors
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact

There are more than 3 million people in the United States with IBD.

There are more than 3 million people in the United States with IBD.

Our Company

We are a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with GI and liver diseases.

Latest News

December 23, 2022

Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement


November 14, 2022

Metacrine Reports Third-Quarter 2022 Results

Programs

Organovo has acquired the FXR Program. For more information, please go to www.organovo.com

© 2023 Metacrine   |   12657 Alcosta Boulevard, Suite 500, San Ramon, CA 94583
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact
  • Leadership & Board of Directors
  • Investors
    ▼
    • Financials & Filings
    • Sec Filings
    • Investor Resources
    • IR Contact
  • Contact